Back/Earned Media GEO Turns AI into Clinical Discovery Tool — Impact on HUTCHMED (China)
AI·February 11, 2026·hcm

Earned Media GEO Turns AI into Clinical Discovery Tool — Impact on HUTCHMED (China)

ED
Editorial
Cashu Markets·3 min read
TL;DR
  • Over 800 million people use AI for answers each week.
  • 94% of links cited by AI systems come from non-paid media.
  • Credible earned-media placements are crucial for biopharma firms like HUTCHMED (China).

AI-driven media becomes clinical discovery tool for drugmakers

Earned coverage as the backbone of LLM-driven clinical discovery

HCM, a PR agency focused on impact-driven brands, is expanding Generative Engine Optimization (GEO) services that position earned media as the primary source LLMs cite when answering healthcare queries. The firm says more than 800 million people use AI for answers weekly and that 94% of links cited by those AI systems come from non-paid media, a dynamic that makes credible media placements crucial for biopharmaceutical companies such as HUTCHMED (China). The development shifts communications strategy from chasing algorithms to building authoritative narratives that large language models will surface to patients, clinicians and partners.

HCM’s GEO approach fuses traditional media relations with LLM-ready educational explainers and multi-channel syndication, aiming to create the trust signals that drive AI discovery. The agency combines data-driven story ideation, prompt engineering and targeted syndication so that high-credibility coverage is amplified across owned channels, newsletters and social platforms, increasing the chance that models such as ChatGPT, Claude and Gemini reference a company’s materials when responding to queries on disease, trial results or drug safety. CEO Hannah Cranston frames the work as amplifying, not replacing, conventional PR: without clear, widely distributed narratives, she says, AI has little reliable content to reference.

For biopharma firms, the implication is significant: clinical trial results, safety updates and educational materials must be crafted both for human reporters and for LLM ingestion to ensure accurate downstream discovery. GEO is presented as infrastructure that sustains visibility over time, helping companies control the framing of complex scientific outcomes and reducing the risk that AI-driven answers surface incomplete or misleading sources when patients and healthcare professionals seek information.

Early client outcomes illustrate practical gains

HCM cites client cases where educational content and strategic earned placements drive measurable traffic and AI visibility: one client sees a 400% website traffic increase after positioning educational material in response to a major study; a social fitness platform achieves prominent placement in AI-generated recommendations following syndicated coverage in outlets including Business Insider; and a wellness brand secures durable LLM-driven discovery through timely newsjacking and tabloid placement.

GEO’s proprietary methodology compounds authority signals by pairing earned credibility with explainers optimized for LLMs and amplifying them across channels. For companies in the pharmaceutical and healthcare sectors, HCM positions the approach as a strategic investment to protect reputation, improve discovery of clinical information and ensure authoritative sources surface in AI-powered patient and clinician queries.

Cashu Markets
Cashu
Markets

By Cashu Markets. Providing market news, analysis, and research for investors worldwide.

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Markets is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Markets is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Markets and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Cashu Markets
Cashu
Markets

Setting up your session...